HCWB
HCW Biologics Inc.
Key Financials
Gross Profit
$10846
↓ 98.9%
Revenue
$6.5M
N/A
EPS (Diluted)
$-10.63
↓ 1280.5%
Net Income
$-7959709
↑ 73.5%
Operating Income
$-13162510
↑ 55.4%
Total Assets
$24.5M
↓ 18.9%
Total Liabilities
$21.8M
↓ 41.2%
Shareholders' Equity
$2.8M
↑ 140.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/16/2026 | View on SEC |
| 8-K | 6/15/2026 | View on SEC |
| D | 6/8/2026 | View on SEC |
| S-1 | 6/8/2026 | View on SEC |
| 8-K | 6/1/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 8-K | 5/27/2026 | View on SEC |
| 8-K | 5/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HCWB |
| Company Name | HCW Biologics Inc. |
| CIK | 1828673 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 954-842-2024 |